Treatment of Hypoglycemia
For conscious patients with hypoglycemia (glucose <70 mg/dL), immediately administer 15-20 grams of oral glucose or any carbohydrate containing glucose, and recheck blood glucose in 15 minutes; for unconscious or unwilling patients, administer 1 mg intramuscular/subcutaneous glucagon or 25 grams intravenous glucose. 1, 2
Immediate Treatment Algorithm
For Conscious Patients (Able to Swallow)
Critical caveat: The glycemic response to oral glucose is transient, typically lasting less than 2 hours in insulin-induced hypoglycemia 2. Therefore, follow up with a more substantial snack or meal once glucose normalizes to prevent recurrence 2.
For Unconscious or Unable to Swallow
Two parenteral options exist:
Glucagon 1.0 mg subcutaneous or intramuscular (administered by family/caregiver) 2
- Can be lifesaving
- Warning: Often causes substantial transient hyperglycemia and may cause nausea/vomiting 2
Intravenous glucose 25 grams (medical personnel) 2
- Standard in hospital/emergency settings
- May require subsequent glucose infusion
- Provide oral food as soon as patient can safely swallow 2
Level-Specific Considerations
The 2025 ADA guidelines define three hypoglycemia levels 1:
- Level 1 (54-69 mg/dL): Treat with oral carbohydrates as above
- Level 2 (<54 mg/dL): Requires immediate action—neuroglycopenic symptoms begin at this threshold 1
- Level 3 (severe): Altered mental status—requires parenteral treatment 1
Essential Prevention Measures
After any hypoglycemic episode:
- One or more episodes of level 2 or 3 hypoglycemia mandates reevaluation of the treatment plan 1
- Consider deintensifying or switching diabetes medications 1
- All individuals taking insulin or at high risk must have glucagon prescribed 1
- Provide structured education on hypoglycemia prevention and treatment 1
Common Pitfalls to Avoid
Sulfonylurea-induced hypoglycemia: Can cause prolonged hypoglycemia requiring hospitalization and extended observation 2. Octreotide has been used in these cases 2.
Post-treatment hyperglycemia: While glucose must be raised promptly to prevent brain damage, avoid excessive post-treatment hyperglycemia, particularly after profound, prolonged hypoglycemia 2
Transient response: The most common error is failing to provide follow-up nutrition after initial treatment, leading to recurrent hypoglycemia 2
Impaired awareness: Screen annually for hypoglycemia unawareness; a 2-3 week period of scrupulous hypoglycemia avoidance can restore awareness 2
Emerging Evidence Considerations
Recent research suggests the traditional "15 grams/15 minutes" rule may need refinement 3, 4, 5. A 2024 trial found that treating at higher thresholds (≤90 mg/dL vs <70 mg/dL) with 16g carbohydrates reduced time in hypoglycemia and prevented 66% of hypoglycemic events 5. However, the 2025 ADA guidelines remain the authoritative standard 1, and these newer approaches require validation before routine implementation.
The evidence base for hypoglycemia treatment in type 2 diabetes is particularly limited, with only three small studies available 4. The current recommendations apply broadly but are predominantly derived from type 1 diabetes studies 2, 6.